Unlearn.ai
Predict clinical trial outcomes using AI-powered patient digital twins
工具指南
探索不同部分
造訪量
12
按讚數
0
品質評分
50/100
功能特色
AI-generated patient models predicting clinical outcomes with precision
EMA-qualified methods meeting FDA guidance requirements
Explore predicted outcomes for any subgroup at any time
Identifies most sensitive clinical outcomes for trials
定價
定價模式
N/A
有免費版本
否
具有 API 存取權限
不可用
平台支援
技術資訊
SSL 安全
否
API 存取
不可用
發現時間Invalid Date
常見問題
How do digital twins improve clinical trials?
They predict individual patient outcomes using AI, allowing researchers to simulate trials and optimize study designs before recruiting real participants.
Is Unlearn's methodology regulator-approved?
Yes, their approach is qualified by the European Medicines Agency and aligns with FDA guidance for clinical trial design.
What diseases does Unlearn support?
Currently focuses on neuroscience (like Alzheimer's), immunology, and metabolic diseases, with expansion capabilities.
社群媒體
社群媒體